{"entity":{"id":"nct07372079","kind":"trial","name":"Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemoth","aka":[],"tldr":"A phase 2 trial in triple-negative breast cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting.","summary":"Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy is a phase 2, interventional study registered as NCT07372079 by Tianjin Medical University Cancer Institute and Hospital, with a registry enrolment figure of 40 participants, started 2026-04-05 and due to reach its primary completion in 2028-12-30. Interventions recorded: QL1706 combined with Chemotherapy. Conditions listed: Breast Cancer; Neoadjuvant Therapy; Immune Checkpoint Inhibitors; QL1706. Triple-negative eligibility wording from the registry: \"* Histopathologically confirmed early-stage triple-negative invasive breast cancer as defined by the latest ASCO/CAP guidelines;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07372079","url":"https://clinicaltrials.gov/study/NCT07372079"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07372079","phase":"2","setting":"Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy","sponsor":"Tianjin Medical University Cancer Institute and Hospital","enrolled":40,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07372079/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}